Marshall Wace North America’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-600
Closed -$23K 1854
2019
Q1
$23K Buy
+600
New +$24.6K ﹤0.01% 1376
2018
Q4
Sell
-8,286
Closed -$566K 1742
2018
Q3
$566K Sell
8,286
-192,983
-96% -$11.9M ﹤0.01% 688
2018
Q2
$10.5M Buy
+201,269
New +$10M 0.06% 323
2017
Q4
Sell
-482,242
Closed -$26.5M 1736
2017
Q3
$26.5M Buy
482,242
+216,136
+81% +$11.9M 0.17% 167
2017
Q2
$16M Buy
266,106
+254,731
+2,239% +$14.3M 0.12% 224
2017
Q1
$626K Buy
+11,375
New +$608K ﹤0.01% 780
2013
Q4
$3.9M Buy
+218,631
New +$3.78M 0.08% 213

Other funds holding CBM

Marshall Wace North America's CBM Position: Q2 2019 in Review

Marshall Wace North America sold out of Cambrex Corporation (CBM) in Q2 2019, closing a stake of 600 shares — an estimated $23K sold.

Marshall Wace North America first reported a position in CBM in Q4 2013 and held it in 7 quarters. The position peaked at $26.5M in Q3 2017. 201 funds tracked by Wall St. Rank hold CBM as of Q2 2019.

  • Marshall Wace North America reported no remaining Cambrex Corporation position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 600 Cambrex Corporation shares in Q2 2019, an estimated $23K.
  • Marshall Wace North America first reported a position in Cambrex Corporation in Q4 2013 and held it in 7 quarters.
  • Marshall Wace North America's Cambrex Corporation position peaked at $26.5M in Q3 2017.
  • 201 funds tracked by Wall St. Rank held Cambrex Corporation as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.